Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy

Fertility and Sterility

Volumn 68, Issue 2, 1997, Pages 236-241

  Valentino, Rossella ^a,b   Dorato, Maurizio ^a   Tommaselli, Antonio Pasquale ^a   Rossi, Riccardo ^a   Savastano, Silvia ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

11 hydroxylase; 21 hydroxylase; 3 olo dehydrogenase; Hyperandrogenism; Oligomenorrhea; PCOS

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; STEROID 11BETA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

ADULT; ARTICLE; ENZYME REGULATION; FEMALE; FOLLICULAR PHASE; HIRSUTISM; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HYPERANDROGENISM; ITALY; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; PRIORITY JOURNAL; PROVOCATION TEST; STEROIDOGENESIS; STIMULUS RESPONSE;

EID: 0343036253     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81508-7     Document Type: Article

References (24)

1. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16:322-53.
2. Valentino R, Tommaselli AP, Rossi R, Lombardi G, Varrone S. A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11β-hydroxylase deficiency in Campania region. J Endocrinol Invest 1990; 13: 221-5.
3. White PC, New MI, Dupont BD. Congenital adrenal hyperplasia. N Engl J Med 1987;316:1519-24.
4. Miller WL. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994;78:241-6.
5. White PC, Curnow KM, Pascoe L. Disorders of steroid 11β-hydroxylase isozymes. Endocr Rev 1994; 15:421-38.
6. Chrousos GP, Loriaux D, Mann DL, Cutler GB. Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med 1982;96:143-8.
7. Siegel SF, Finegold DN, Lanes R, Lee PA. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. N Engl J Med 1990;323:849-54.
8. Eldar-Geva T, Hurwitz A, Vecsei P, Palti Z, Milwidsky A, Rosier A. Secondary biosynthetic defects in women with lateonset congenital adrenal hyperplasia. N Engl J Med 1990; 323:855-63.
9. Dunaif A. Adrenal disorders and polycystic ovary syndrome. Horm Res 1992;37:39-44.
10. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992;327:157-62.
11. Azziz R, Zacur HA. 21-hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 1989;69:577-84.
12. De Simone G, Tommaselli AP, Rossi R, Valentino R, Lauria R, Scopacasa F, et al. Partial deficiency of adrenal 11β-hydroxylase: a possible cause of primary hypertension. Hypertension 1985;7:204-10.
13. Ferriman D, Galloway JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7.
14. New MI, Lorenzen F, Lener AJ, Kohn B, OberfieldSE, Pollack MS, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metabol 1983; 57: 320-5.
15. Zerah M, Ueshiba H, Wood E, Speiser PW, Crawford C, McDonald T, et al. Prevalence of non-classical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study. J Clin Endocrinol Metab 1990;70:1662-7.
16. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome P450cl7α as the cause of polycystic ovarian syndrome. Fertil Steril 1990;53:785-91.
17. Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3β-hydroxydelta5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab 1993; 76:450-5.
18. Levine LS, Dupont BO, Lorenzen F, Pang S, Pollack M, Ober-field SE, et al. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab 1981;54:1193-8.
19. Penny R, Vecsei P. Congenital adrenal hyperplasia due to combined 21-and 11β-hydroxylase deficiency. J Endocrinol Invest 1989; 12:723-8.
20. Portales JAR, Arteaga E, Moreno JML, Biglieri EG. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1988;66:349-54.
21. Fiet J, Gueux B, Raux-Demay MC, Kuttenn F, Vexiau P, Brerault JL, et al. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway. J Clin Endocrinol Metab 1989;68:542-7.
22. Azziz R, Boots LR, Parker CR Jr, Bradley E Jr, Zacur HA. 11β-hydroxylase deficiency in hyperandrogenism. Fertil Steril 1991;55:733-41.
23. Pang S, Lerner AJ, Stoner E, Levine LS, Oberfield SE, Engel I, et al. Late-onset adrenal steroid 3β-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J Clin Endocrinol Metab 1985;60:428-39.
24. Young J, Couzinet B, Pholsena M, Nahoul K, Labrie F, Schaison G. Plasma 3β-hydroxy-delta5-steroids in patients with congential adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994:78:299-304.